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The gene encompasses 2,366 bps (chr2:20,510,316-
20,512,681); 1 exon. 
Transcription 
The coding sequence (CDS) region is 395.983 bp (588 
bp) encoding a protein of 196 aa long. 
Protein 
Description 
Length 196 aa, molecular weight 22123 Da 
(unprocessed precursor). RhoB protein exists in 
different geranylgeranylated (RhoB-GG) or 




Endosome; Late endosome; late endosomal membrane; 
cell membrane; Also detected at the nuclear margin and 
in the nucleus. Prenylation specifies the subcellular 
location of RHOB. In general, the farnesylated form is 
localized to the plasma membrane while the 
geranylgeranylated form is localized to the endosome. 
Function 
Regulator of protein signaling and trafficking:  
Plays a pivotal role in the dynamic regulation of the 
actin cytoskeleton. Involved in intracellular protein 
trafficking of a number of proteins. Targets PRK1 to 
endosomes and is involved in trafficking of the EGF 
receptor from late endosomes to lysosomes. Also 
required for stability and nuclear trafficking of Akt 
which promotes endothelial cell survival during 
vascular development. Identified as a component of 
outside-in signaling pathways that coordinate Src 
activation with its translocation to transmembrane 
receptors. 
Negative modifier of cancer progression:  
Affects cell adhesion and growth factor signaling in 
transformed cells. Plays a negative role in 
tumorigenesis as RhoB deletion increases tumor 
formation initiated by Ras mutation. Limits the 
proliferation of transformed cells by facilitating 
turnover of oncogene c-Myc. Expression levels are 
dramatically decreased in lung, head and neck, and 
brain cancer, when tumors become more aggressive. 
Modulator of cancer cell apoptosis:  
Promotes proapoptotic signaling of regulators involved 
in cell cycle checkpoints, cell adhesion, vesicle 
trafficking, MAPK signaling, transcription, and 
immunity. Mediates apoptosis in neoplastically 
transformed cells after DNA damage. Is essential for 
apoptosis and antineoplastic activity of 
farnesyltransferase inhibitors in a mouse model. Is one 
of the targets of farnesyltransferase inhibitors which are 
currently under investigation as cancer therapeutics. 
Homology 
Member of the ras gene superfamily; rho family; GTP-
binding proteins. The RhoA, RhoB, and RhoC proteins 
form a closely related subgroup that are about 90% 
identical in amino acid sequence. The sequences of 
RHOB are highly-conserved between species (from 
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human to fly). Amino acid sequences of human, mouse 
and rat are 100% identical while sequence homology 
between human and chicken is 97% identical. 
Implicated in 
Lung cancer 
Note: RhoB expression is frequently downregulated in 
lung cancer by multiple mechanisms. Low or no 
expression of RhoB is more frequently observed in 
poorly- or moderately-differentiated adenocarcinomas, 
and indicative of poor patient prognosis. 
Head and neck cancer 
Note: RhoB expression decreases to undetectable level 
as tumors become more invasive and poorly 
differentiated. In contrast, Ki67 (proliferation marker) 
and RhoA protein levels increase with tumor 
progression. 
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